Tokyo, Sept. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062966) titled 'A Study on the Efficacy of TF-CBT for Trauma-Related Disorders Caused by D... Read More
Tokyo, Sept. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062950) titled 'Effects of 15-minute water walking in a hydrogen pool on blood flow' on Se... Read More
Tokyo, Sept. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059153) titled 'Clinical Study of Psychological Impact of Food Ingredients: a placebo-cont... Read More
China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The relationship between blood lipids and pregnancy outcomes in women with gestational... Read More
China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Effect of SFBT Combined with Self-Efficacy Intervention in Breast Cancer ... Read More
China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective clinical study on the efficacy, safety and recurrence of oral isotretino... Read More
China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the effect of mindfulness-based stress reduction therapy on the symptoms and ... Read More
China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prospective multicenter cohort study of multi-dimensional joint screening in early pre... Read More
China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of First-Line Therapy with Gemox Chemotherapy Combined with Lenvat... Read More
China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An open-label, multicenter study of MRG001 combined with Lenalidomide/ Orelabrutinib i... Read More